Amundi Asset Management US
CLVS

Amundi Asset Management US’s Clovis Oncology, Inc. CLVS Stock Holding History

Amundi Asset Management US’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-258,176
Closed -$6.41M – 1716
2019
Q1 		$6.41M Sell
258,176
-6,924
-3% -$174K 0.01% 809
2018
Q4 		$4.76M Sell
265,100
-107,200
-29% -$2.19M ﹤0.01% 842
2018
Q3 		$10.9M Buy
372,300
+89,000
+31% +$3.45M 0.01% 715
2018
Q2 		$12.9M Buy
283,300
+84,300
+42% +$4.1M 0.02% 654
2018
Q1 		$10.5M Buy
199,000
+146,200
+277% +$8.53M 0.02% 668
2017
Q4 		$3.59M Buy
+52,800
New +$3.69M 0.01% 936

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Amundi Asset Management US's CLVS Position: Q2 2019 in Review

Amundi Asset Management US sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 258,176 shares — an estimated $6.41M sold.

Amundi Asset Management US first reported a position in CLVS in Q4 2017 and held it in 6 quarters. The position peaked at $12.9M in Q2 2018. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

  • Amundi Asset Management US reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 258,176 Clovis Oncology, Inc. shares in Q2 2019, an estimated $6.41M.
  • Amundi Asset Management US first reported a position in Clovis Oncology, Inc. in Q4 2017 and held it in 6 quarters.
  • Amundi Asset Management US's Clovis Oncology, Inc. position peaked at $12.9M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Amundi Asset Management US's 13F filing for Q2 2019, filed 14 Aug 2019.